C2I GENOMICS
Live / Registered — Registered (as of 27 Feb 2024)
What this means for you
Registered since 27 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88956265
- Registration number
- 7316541
- Mark type
- Stylized text
- Filed
- 09 Jun 2020
- Published for opposition
- 20 Oct 2020
- Registered
- 27 Feb 2024
- Attorney of record
- Rosaleen H. Chou
Goods and services
- Class 042 — Scientific and technological services: Software-as-a-Service (SaaS) services featuring software and Platform-as-a-Service (PaaS) services feature computer software platforms in the nature of non-downloadable computer software, non-downloadable computer applications, and web-based software, all for accessing cloud-based servers and remote client servers for measuring post-surgical cancer burden scores through bioinformatics and artificial intelligence, analyzing genetic patterns post-surgery, providing medical and cancer treatment recommendation, and providing cancer and medical treatment monitoring throughout the patient cancer encounter for use by health systems, oncologists, physicians, cancer clinics, medical professionals, and hospitals
Owner
- VERACYTE DIAGNOSTICS, LLC, New York, NY, US
- C2i Genomics, Inc., New York, NY, US
- C2i Genomics, Inc., New York, NY, US
- C2i Genomics, Inc., New York, NY, US
Prosecution history
- 06 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Aug 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Aug 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Aug 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Aug 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Jul 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 27 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 20 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Dec 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Dec 2023 — USE AMENDMENT FILED
- 14 Dec 2023 — TEAS STATEMENT OF USE RECEIVED
- 01 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 May 2023 — SOU EXTENSION 5 GRANTED